PATENTS OFFICE JOURNAL - Irish Patents Office
PATENTS OFFICE JOURNAL - Irish Patents Office
PATENTS OFFICE JOURNAL - Irish Patents Office
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(20/04/2005) <strong>Patents</strong> <strong>Office</strong> Journal (No. 2018)<br />
20040177<br />
Polymer microfluidic device integration. NANOCOMMS <strong>PATENTS</strong><br />
LIMITED<br />
20040178<br />
A search engine and method. UNIVERSITY COLLEGE DUBLIN,<br />
NATIONAL UNIVERSITY OF IRELAND, DUBLIN<br />
20040180 A device. ATROPOS LIMITED<br />
20040181 A device. ATROPOS LIMITED<br />
20040183 A device. ATROPOS LIMITED<br />
Deemed to be Withdrawn – Section 31(3)<br />
20010986 Int.Cl.7 G06F 15/163;G06F 17/30. Selective distribution of electronic files<br />
via a common access platform. VHSoft I P COMPANY LIMITED<br />
Withdrawn – Section 33(1)<br />
S20040165 A health drink. DELLA McHUGH; KEVIN McHUGH<br />
Request for Grant of Supplementary Protection Certificate<br />
The name and address of the requestor follow the number allocated to the request. The date in brackets<br />
following the name and address is the date of receipt of the request. The Patent number is that under which<br />
the product in respect of which a certificate is sought is, allegedly, protected. Market Authorisation<br />
references in respect of the product concerned are also shown.<br />
2005008 THE TRUSTEES OF PRINCETON UNIVERSITY, P.O. Box 36,<br />
Nassau St. Princeton, New Jersey 085544, United States of America<br />
(15 March 2005)<br />
Patent No: 82554; N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid<br />
derivatives<br />
Product: Pemetrexed and pharmaceutically acceptable salts thereof<br />
Market Authorisation: Ireland EU/1/04/290/001, 20/09/2004<br />
2005009 SMITHKLINE BEECHAM CORPORATION, One Franklin Plaza,<br />
200 North 16th Street, Philadelphia, PA 19102, United States of<br />
America<br />
(18 March 2005)<br />
Patent No: 0719278; ANDROSTENONE DERIVATIVE<br />
Product: Dutasteride, optionally in the form of a pharmaceutically<br />
acceptable solvate.<br />
Market Authorisation: Ireland 1077/104/01, 17/12/2004<br />
Ireland 1077/105/1, 17/12/2004<br />
6607